Intravitreal bevacizumab for posterior capsule neovascularization
SJO-Saudi Journal of Ophthalmology. 2010; 24 (2): 63-65
in English
| IMEMR
| ID: emr-98430
ABSTRACT
We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab [Avastin] followed by neodymiumYAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Treatment Outcome
/
Angiogenesis Inhibitors
/
Vascular Endothelial Growth Factor A
/
Antibodies, Monoclonal
Type of study:
Case report
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
Saudi J. Ophthalmol.
Year:
2010
Similar
MEDLINE
...
LILACS
LIS